|
|
| | 1H-Indole-3-propanamide, N-[[(1R,3S)-3-(aminomethyl)cyclohexyl]methyl]-α-[[[4-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]carbonyl]amino]-β-methyl-, (αR,βS)- Basic information |
| Product Name: | 1H-Indole-3-propanamide, N-[[(1R,3S)-3-(aminomethyl)cyclohexyl]methyl]-α-[[[4-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]carbonyl]amino]-β-methyl-, (αR,βS)- | | Synonyms: | 1H-Indole-3-propanamide, N-[[(1R,3S)-3-(aminomethyl)cyclohexyl]methyl]-α-[[[4-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]carbonyl]amino]-β-methyl-, (αR,βS)-;976;L 779976;L779976;L-779976 | | CAS: | 214770-19-1 | | MF: | C33H43N7O3 | | MW: | 585.75 | | EINECS: | | | Product Categories: | | | Mol File: | 214770-19-1.mol | ![1H-Indole-3-propanamide, N-[[(1R,3S)-3-(aminomethyl)cyclohexyl]methyl]-α-[[[4-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]carbonyl]amino]-β-methyl-, (αR,βS)- Structure](CAS/20211123/GIF/214770-19-1.gif) |
| | 1H-Indole-3-propanamide, N-[[(1R,3S)-3-(aminomethyl)cyclohexyl]methyl]-α-[[[4-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]carbonyl]amino]-β-methyl-, (αR,βS)- Chemical Properties |
| density | 1.254±0.06 g/cm3(Predicted) | | pka | 12.02±0.30(Predicted) |
| | 1H-Indole-3-propanamide, N-[[(1R,3S)-3-(aminomethyl)cyclohexyl]methyl]-α-[[[4-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]carbonyl]amino]-β-methyl-, (αR,βS)- Usage And Synthesis |
| Uses | L-779976 is a compound with bradykinin agonist activity. Injection into the amygdala and septum of the rat brain can produce anxiolytic effects. Its bradykinin agonist activity has been verified by relevant experiments. | | Definition | ChEBI: L-779976 is a member of the class of indoles that is (betaS)-beta-methyl-D-tryptophan in which the primary amino group undergoes formal condensation with the carboxy group of 4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidine-1-carboxylic acid and the carboxy group undegoes formal condensation with the amino group of (1R,3S)-cyclohexane-1,3-diyldimethanamine. It is a selective nonpeptidic agonist of the somatostatin subtype-2 (SST2) receptor with Ki of 0.05 nM. It has a role as a somatostatin receptor agonist and a neuroprotective agent. It is a secondary carboxamide, a primary amino compound, a member of indoles, a member of benzimidazoles and a piperidinecarboxamide. | | References | [1] The anxiolytic effects of somatostatin following intra-septal and intra-amygdalar microinfusions are reversed by the selective sst2 antagonist PRL2903 DOI:10.1016/j.pbb.2011.12.012 |
| | 1H-Indole-3-propanamide, N-[[(1R,3S)-3-(aminomethyl)cyclohexyl]methyl]-α-[[[4-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]carbonyl]amino]-β-methyl-, (αR,βS)- Preparation Products And Raw materials |
|